North America Skin Cancer Diagnostics Market Forecast 2023-2032

North America Skin Cancer Diagnostics Market Forecast 2023-2032


KEY FINDINGS

The North America skin cancer diagnostics market is expected to grow with a 7.28% CAGR during the estimation period 2023-2032. The market growth is driven by heavy R&D investments and a rapid increase in melanoma cases in the region.

MARKET INSIGHTS

The North America skin cancer diagnostics market growth evaluation covers a thorough assessment of Canada and the United States. Canada holds a prominent position globally in terms of national health expenditure. The Canadian Institute for Health Information has projected that the nation’s total health spending is expected to touch $331 billion in 2022, which amounts to $8,563 per capita.

The Canadian government, recognizing the severity of this health crisis, has committed to intensifying efforts to tackle skin cancer. The Public Health Agency of Canada (PHAC), responsible for monitoring cancer trends in the country, plays a pivotal role in identifying risk factors, strategizing programs for risk reduction, and researching environmental and behavioral hazards. Furthermore, Health Canada spearheads initiatives to raise public awareness about sun safety and the detrimental effects of UV radiation.

The continued escalation in skin cancer prevalence, coupled with an unwavering commitment from governmental and private entities to elevate public consciousness about early cancer detection and preventive measures, is anticipated to serve as critical catalysts propelling the market growth.

COMPETITIVE INSIGHTS

Some of the leading market players include Dermlite LLC, Castle Biosciences Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Increasing Application Of Ai And Machine Learning In Skin Cancer Diagnosis Tools
3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Prevalence Of Skin Cancer
3.1.2. Growing Awareness About Skin Cancer Diagnosis & Treatment
3.1.3. Technological Advancements In Skin Cancer Diagnostic Products
3.2. Key Restraints
3.2.1. High Costs Associated With Skin Cancer Treatments
3.2.2. Stringent Regulatory Framework
3.2.3. Lack Of Skilled Medical Professionals
4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Concentration Analysis
4.6. Value Chain Analysis
4.6.1. Research And Development
4.6.2. Manufacturing
4.6.3. Marketing And Sales
4.6.4. Distribution And Logistics
4.6.5. Training And Support
5. Market By Type
5.1. Melanoma
5.2. Non-melanoma
6. Market By Gender
6.1. Male
6.2. Female
7. Market By Screening Type
7.1. Skin Biopsy
7.2. Dermatoscopy
7.3. Lymph Node
7.4. Biopsy Imaging Tests
7.5. Blood Tests
8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. North America Skin Cancer Diagnostics Market Drivers
8.1.3. North America Skin Cancer Diagnostics Market Challenges
8.1.4. Key Players In North America Skin Cancer Diagnostics Market
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.1.1. United States Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.2. Canada
8.1.5.2.1. Canada Skin Cancer Diagnostics Market Size & Opportunities
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Product Launches & Developments
9.1.2. Partnerships & Agreements
9.2. Company Profiles
9.2.1. Amlo Biosciences Limited
9.2.2. Biomerieux Sa
9.2.3. Castle Biosciences Inc
9.2.4. Dermlite Llc
9.2.5. Dermtech Inc
9.2.6. F. Hoffmann-la Roche Ltd
9.2.7. Michelson Diagnostics Ltd
9.2.8. Neracare Gmbh
9.2.9. Skylinedx Bv
9.2.10. Veriskin Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings